Accelerating research

and development of

new antibiotics and

alternatives

About NADP

The Netherlands Antibiotic Development Platform (NADP) facilitates the collaboration between public and private organisations aimed at developing new antibiotics and alternative therapies, from initial idea to final product. The application is focused on human and animal health, both in prevention and care. While academic institutions have a focus on fundamental and precompetitive research to discover and characterise new antibiotic and alternative leads, NADP provides a platform that facilitates the ensuing public-private collaborations.

NADP Partners

The NADP partners are the Centre for Antimicrobial Research (CARES), the Centre for Sustainable Antimicrobials (CeSAM), the network organisation Immuno Valley, and the Netherlands Centre for One Health (NCOH).

Read more about the NADP partner organisations here.

Governance

NADP Governance v2

Organisation

NADP is a collaborative effort of its partners CARES, CeSAM, Immuno Valley, and NCOH and is supported by the Dutch Ministry of Health, Welfare, and Sport (VWS). Funding is provided through a financial grant from the Ministry of VWS. Immuno Valley provides alliance management and communication support. NADP is strategically and organisationally embedded within NCOH, in particular within its Strategic Research Theme Tackling Antimicrobial Resistance (NCOH-AMR). The NCOH-AMR is organised through so-called Solution Sets. Within NCOH-AMR, the NADP will provide a platform for public-private partnerships in the Solution Sets "New Antibiotics" and "New Alternatives". While the NCOH has an academic, precompetitive focus and provides the research platform in which antibiotic and alternative leads are discovered and characterised, the NADP facilitates the ensuing public-private collaborations and provides a platform in which academic and industrial partners can meet.